2 New Hepatitis C Abstract Links

[Guest guest]

ACH-1625 HCV Protease Inhibitor Starts Phase 2

TrialSUMMARY

Achillion Pharmaceuticals recently announced that the

first patients have started treatment in a Phase 2 clinical

trial of the experimental HCV protease inhibitor ACH-1625

plus pegylated interferon and ribavirin.Gene Variation

Linked to Liver Cancer in Hepatitis C PatientsSUMMARY

A genome-wide association study looking at more than

460,000 single nucleotide changes found that a variation

in the DEPDC5 gene on chromosome 22 is associated with

increased risk of hepatocellular carcinoma in people

with hepatitis C.